Group 1 - The company announced a conditional sale agreement involving approximately 1.8485 billion shares, representing about 20.31% of its total issued share capital, for a consideration of approximately HKD 3.142 billion [1] - Following the completion of the sale agreement, the largest shareholder will change, with the buyer, a wholly-owned subsidiary of Hua Jian Medical, becoming the single largest shareholder [2] - The board anticipates that the sale and change in the largest shareholder will not have any significant adverse impact on the company's daily operations [2] Group 2 - After the transaction, Dr. Liu Zhiwei will hold approximately 8.8328 million shares (about 0.97% of the issued share capital), and Mr. Wang will hold approximately 9.0373 million shares (about 0.99% of the issued share capital) [2] - The company has applied to the Stock Exchange to resume trading of its shares from September 1, 2025, at 1:00 PM [2]
国富量子单一最大股东将变更为华检医疗 下午复牌